Risk genes for schizophrenia: Translational opportunities for drug discovery

Pharmacology and Therapeutics

Volumn 143, Issue 1, 2014, Pages 34-50

  Winchester, Catherine L ^a,b   Pratt, Judith A ^a,b   Morris, Brian J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Gene; Polymorphism; Schizophrenia; Stratified medicines; Therapeutics; Variant

Indexed keywords

1,4 DIAZABICYCLO[3.2.2]NONANE 4 CARBOXYLIC ACID 4 BROMOPHENYL ESTER; ASENAPINE; FARAMPATOR; GLUTAMIC ACID; GSK 644784; GSK 729327; ILOPERIDONE; LURASIDONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEBOGLAMINE; OMS 824; PALIPERIDONE; PF 02545920; TAK 063; TC 5619; UNCLASSIFIED DRUG; ZIPRASIDONE; TRANSCRIPTOME;

AKT GENE; ARTICLE; CHRNA7 GENE; COPY NUMBER VARIATION; CYTOGENETICS; DISC1 GENE; DPYSL2 GENE; DRUG TARGETING; EPIGENETICS; ERBB4 GENE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GRM3 GENE; HUMAN; LINKAGE ANALYSIS; MAP2K7 GENE; METABOLOMICS; MIR137 GENE; NEUROBIOLOGY; NONHUMAN; NRG1 GENE; PDES GENE; PRIORITY JOURNAL; PROTEOMICS; RISK FACTOR; SCHIZOPHRENIA; SYSTEMS BIOLOGY; TAOK2 GENE; TNIK GENE; TRANSCRIPTOMICS; VIPR2 GENE; ANIMAL; DRUG DEVELOPMENT; GENE DOSAGE; GENETICS; PHYSIOLOGY;

ANIMALS; DRUG DISCOVERY; EPIGENOMICS; GENE DOSAGE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PROTEOMICS; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SYSTEMS BIOLOGY; TRANSCRIPTOME;

EID: 84898914426     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2014.02.003     Document Type: Review

References (242)

1. H.M. Abdolmaleky, K.H. Cheng, S.V. Faraone, M. Wilcox, S.J. Glatt, and F. Gao et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder Hum Mol Genet 15 21 2006 3132 3145 (Pubitemid 44607800)
2. H.M. Abdolmaleky, K.H. Cheng, A. Russo, C.L. Smith, S.V. Faraone, and M. Wilcox et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report Am J Med Genet B Neuropsychiatr Genet 134B 1 2005 60 66 (Pubitemid 40411111)
3. H.M. Abdolmaleky, and S. Thiagalingam Can the schizophrenia epigenome provide clues for the molecular basis of pathogenesis? Epigenomics 3 2011 679 683
4. N.C. Allen, S. Bagade, M.B. McQueen, J.P. Ioannidis, F.K. Kavvoura, and M.J. Khoury et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database Nat Genet 40 2008 827 834 (Pubitemid 351913655)
5. P. Anderson, and E. Gonzalez-Rey Vasoactive intestinal peptide induces cell cycle arrest and regulatory functions in human T cells at multiple levels Mol Cell Biol 30 2010 2537 2551
6. D. Arion, T. Unger, D.A. Lewis, and K. Mirnics Molecular markers distinguishing supragranular and infragranular layers in the human prefrontal cortex Eur J Neurosci 25 2007 1843 1854 (Pubitemid 46549993)
7. L. Athanasiu, M. Mattingsdal, A.K. Kahler, A. Brown, O. Gustafsson, and I. Agartz et al. Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort J Psychiatr Res 44 2010 748 753
8. P. Awadalla, J. Gauthier, R.A. Myers, F. Casals, F.F. Hamdan, and A.R. Griffing et al. Direct measure of the de novo mutation rate in autism and schizophrenia cohorts Am J Hum Genet 87 3 2010 316 324
9. J.A. Badner, and E.S. Gershon Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia Mol Psychiatry 7 2002 405 411 (Pubitemid 34499362)
10. M.G. Banigan, P.F. Kao, J.A. Kozubek, A.R. Winslow, J. Medina, and J. Costa et al. Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients PLoS One 8 2013 e48814
11. C.S. Barros, B. Calabrese, P. Chamero, A.J. Roberts, E. Korzus, and K. Lloyd et al. Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system Proc Natl Acad Sci U S A 106 11 2009 4507 4512
12. A.S. Bassett, and E.W. Chow Schizophrenia and 22q11.2 deletion syndrome Curr Psychiatry Rep 10 2008 148 157
13. A.S. Bassett, C.R. Marshall, A.C. Lionel, E.W. Chow, and S.W. Scherer Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome Hum Mol Genet 17 2008 4045 4053 (Pubitemid 352762863)
14. C. Beasley, D. Cotterm, N. Khan, C. Pollard, P. Sheppard, and I. Varndell et al. Glycogen synthase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia Neurosci Lett 302 2-3 2001 117 120 (Pubitemid 32274223)
15. C.L. Beasley, K. Pennington, A. Behan, R. Wait, M.J. Dunn, and D. Cotter Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes Proteomics 6 11 2006 3414 3425 (Pubitemid 43886157)
16. S.E. Bergen, C.T. O'Dushlaine, S. Ripke, P.H. Lee, D.M. Ruderfer, and S. Akterin et al. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder Mol Psychiatry 17 2012 880 886
17. J.L. Blouin, B.A. Dombroski, S.K. Nath, V.K. Lasseter, P.S. Wolyniec, and G. Nestadt et al. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21 Nat Genet 20 1 1998 70 73 (Pubitemid 28410348)
18. N.J. Bradshaw, D.C. Soares, B.C. Carlyle, F. Ogawa, H. Davidson-Smith, and S. Christie et al. PKA phosphorylation of NDE1 is DISC1/PDE4 dependent and modulates its interaction with LIS1 and NDEL1 J Neurosci 31 2011 9043 9054
19. K.J. Brennand, A. Simone, J. Jou, C. Gelboin-Burkhart, N. Tran, and S. Sangar et al. Modelling schizophrenia using human induced pluripotent stem cells Nature 473 7346 2011 221 225
20. S. Bretin, V. Rogemond, P. Marin, M. Maus, Y. Torrens, and J. Honnorat et al. Calpain product of WT-CRMP2 reduces the amount of surface NR2B NMDA receptor subunit J Neurochem 98 2006 1252 1265 (Pubitemid 44127799)
21. J.M. Brittain, A.D. Piekarz, Y. Wang, T. Kondo, T.R. Cummins, and R. Khanna An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels J Biol Chem 284 2009 31375 31390
22. J.L. Browning, T. Patel, P.C. Brandt, K.A. Young, L.A. Holcomb, and P.B. Hicks Clozapine and the mitogen-activated protein kinase signal transduction pathway: implications for antipsychotic actions Biol Psychiatry 57 6 2005 617 623 (Pubitemid 40409701)
23. J.E. Buizer-Voskamp, J.W. Muntjewerff, Genetic Risk and Outcome in Psychosis (GROUP) Consortium Members, E. Strengman, C. Sabatti, and H. Stefansson et al. Genome-wide analysis shows increased frequency of copy number variation deletions in Dutch schizophrenia patients Biol Psychiatry 70 7 2011 655 662
24. J. Bustillo, M.P. Galloway, F. Ghoddoussi, F. Bolognani, and N. Perrone-Bizzozero Medial-frontal cortex hypometabolism in chronic phencyclidine exposed rats assessed by high resolution magic angle spin 11.7 T proton magnetic resonance spectroscopy Neurochem Int 61 2012 128 131
25. J.H. Callicott, R.E. Straub, L. Pezawas, M.F. Egan, V.S. Mattay, and A.R. Hariri et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia Proc Natl Acad Sci U S A 102 24 2005 8627 8632 (Pubitemid 40862786)
26. L.M. Camargo, V. Collura, J.C. Rain, K. Mizuguchi, H. Hermjakob, and S. Kerrien et al. Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia Mol Psychiatry 12 1 2007 74 86 (Pubitemid 44973664)
27. L.M. Camargo, Q. Wang, and N.J. Brandon What can we learn from the disrupted in schizophrenia 1 interactome: lessons for target identification and disease biology? Novartis Found Symp 289 2008 208 216 (discussion 216-21, 238-40)
28. A.G. Cardno, E.J. Marshall, B. Coid, A.M. Macdonald, T.R. Ribchester, and N.J. Davies et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series Arch Gen Psychiatry 156 2 1999 162 168 (Pubitemid 29081391)
29. C. Centeno, M. Repici, J.Y. Chatton, B.M. Riederer, C. Bonny, and P. Nicod et al. Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons Cell Death Differ 14 2007 240 253 (Pubitemid 46092227)
30. M.R. Chapman, and H.E. Vause Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment Am J Psychiatry 168 2011 245 251
31. Y.J. Chen, M.A. Johnson, M.D. Lieberman, R.E. Goodchild, S. Schobel, and N. Lewandowski et al. Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components J Neurosci 28 27 2008 6872 6883
32. X.X. Chi, B.S. Schmutzler, J.M. Brittain, Y. Wang, C.M. Hingtgen, and G.D. Nicol et al. Regulation of N-type voltage-gated calcium channels (Cav2.2) and transmitter release by collapsin response mediator protein-2 (CRMP-2) in sensory neurons J Cell Sci 122 2009 4351 4362
33. V.Z. Chong, M. Thompson, S. Beltaifa, M.J. Webster, A.J. Law, and C.S. Weickert Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients Schizophr Res 100 1-3 2008 270 280
34. P. Chue Glycine reuptake inhibition as a new therapeutic approach in schizophrenia: focus on the glycine transporter 1 (GlyT1) Curr Pharm Des 19 2012 1311 1320
35. D. Clark, I. Dedova, S. Cordwell, and I. Matsumoto A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia Mol Psychiatry 11 5 2006 459 470 (423)
36. M.P. Coba, N.H. Komiyama, J. Nithianantharajah, M.V. Kopanitsa, T. Indersmitten, and N.G. Skene et al. TNiK is required for postsynaptic and nuclear signaling pathways and cognitive function J Neurosci 32 2012 13987 13999
37. S.M. Cochran, L.J. Steward, M.B. Kennedy, C.E. McKerchar, J.A. Pratt, and B.J. Morris Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs Neuropsychopharmacology 28 2003 265 275
38. N. Craddock, and M.J. Owen The Kraepelinian dichotomy - going, going... but still not gone Br J Psychiatry 196 2 2010 92 95
39. I. Creese, D.R. Burt, and S.H. Snyder Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs Science 192 4238 1976 481 483
40. Cross-Disorder Group of the Psychiatric Genomics Consortium Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis Lancet 381 9875 2013 1371 1379
41. D. Cussac, D. Duqueyroix, A. Newman-Tancredi, and M.J. Millan Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors Psychopharmacology (Berl) 162 2 2002 168 177 (Pubitemid 34743956)
42. B.N. Cuthbert, and T.R. Insel Toward the future of psychiatric diagnosis: the seven pillars of RDoC BMC Med 14 11 2013 126 10.1186/1741-7015-11-126
43. J. Dalmau, E. Lancaster, E. Martinez-Hernandez, M.R. Rosenfeld, and R. Balice-Gordon Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis Lancet Neurol 10 2011 63 74
44. S.R. Datta, A. McQuillin, M. Rizig, E. Blaveri, S. Thirumalai, and G. Kalsi et al. A threonine to isoleucine missense mutation in the pericentriolar material 1 gene is strongly associated with schizophrenia Mol Psychiatry 15 2010 615 628
45. N. Dawson, B.J. Morris, and J.A. Pratt Subanaesthetic ketamine treatment alters prefrontal cortex connectivity with thalamus and ascending subcortical systems Schizophr Bull 39 2 2011 366 377
46. N. Dawson, R.J. Thompson, A. McVie, D.M. Thomson, B.J. Morris, and J.A. Pratt Modafinil reverses phencyclidine-induced deficits in cognitive flexibility, cerebral metabolism, and functional brain connectivity Schizophr Bull 38 2010 457 474
47. N. Dawson, X. Xiao, M. McDonald, D.J. Higham, B.J. Morris, and J.A. Pratt Sustained NMDA Receptor Hypofunction Induces Compromised Neural Systems Integration and Schizophrenia-Like Alterations in Functional Brain Networks Cerebral Cortex 24 12 2014 452 464
48. F.C. de Anda, A.L. Rosario, O. Durak, T. Tran, J. Graff, and K. Meletis et al. Autism spectrum disorder susceptibility gene TAOK2 affects basal dendrite formation in the neocortex Nat Neurosci 15 7 2012 1022 1031
49. J. Decoster, M. De Hert, W. Viechtbauer, G. Nagels, I. Myin-Germeys, and J. Peuskens et al. Genetic association study of the P300 endophenotype in schizophrenia Schizophr Res 141 1 2012 54 59
50. E.L. Dempster, R. Pidsley, L.C. Schalkwyk, S. Owens, A. Georgiades, and F. Kane et al. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder Hum Mol Genet 20 24 2011 4786 4796
51. X. Deng, N. Sagata, N. Takeuchi, M. Tanaka, H. Ninomiya, and N. Iwata et al. Association study of polymorphisms in the neutral amino acid transporter genes SLC1A4, SLC1A5 and the glycine transporter genes SLC6A5, SLC6A9 with schizophrenia BMC Psychiatry 8 2008 58
52. L. Dickson, and K. Finlayson VPAC and PAC receptors: from ligands to function Pharmacol Ther 121 2009 294 316
53. E.F. Domino, and E.D. Luby Phencyclidine/schizophrenia: one view toward the past, the other to the future Schizophr Bull 38 2012 914 919
54. E. Dong, Y. Chen, D.P. Gavin, D.R. Grayson, and A. Guidotti Valproate induces DNA demethylation in nuclear extracts from adult mouse brain Epigenetics 5 8 2010 730 735
55. X. Duan, J.H. Chang, S. Ge, R.L. Faulkner, J.Y. Kim, and Y. Kitabatake et al. Disrupted-in-schizophrenia 1 regulates integration of newly generated neurons in the adult brain Cell 130 6 2007 1146 1158 (Pubitemid 47422304)
56. P.F. Edgar, J.E. Douglas, G.J. Cooper, B. Dean, R. Kydd, and R.L. Faull Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia Mol Psychiatry 5 2000 85 90 (Pubitemid 30088457)
57. M.F. Egan, R.E. Straub, T.E. Goldberg, I. Yakub, J.H. Callicott, and A.R. Hariri et al. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia Proc Natl Acad Sci U S A 101 34 2004 12604 12609 (Pubitemid 39122071)
58. A. Egerton, L. Reid, S. McGregor, S.M. Cochran, B.J. Morris, and J.A. Pratt Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats Psychopharmacology (Berl) 198 2008 37 49
59. A. Egerton, L. Reid, C.E. McKerchar, B.J. Morris, and J.A. Pratt Impairment in perceptual attentional set shifting following PCP administration: a rodent model of cognitive dysfunction in schizophrenia Psychopharmacology (Berl) 179 2005 77 84 (Pubitemid 40576694)
60. H. Eldar-Finkelman, and A. Martinez GSK-3 inhibitors: preclinical and clinical focus on CNS Front Mol Neurosci 4 2011 32 (doi: 10.3389)
61. E. Emamian AKT/GSK3 signaling pathways and schizophrenia Front Mol Neurosci 5 2012 (doi: 10.3389)
62. J.A. English, K. Pennington, M.J. Dunn, and D.R. Cotter The neuroproteomics of schizophrenia Biol Psychiatry 69 2010 163 172
63. M.D. Fallin, V.K. Lasseter, D. Avramopoulos, K.K. Nicodemus, P.S. Wolyniec, J.A. McGrath, G. Steel, G. Nestadt, K.Y. Liang, R.L. Huganir, D. Valle, and A.E. Pulver Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios Am J Hum Genet. 77 6 2005 918 936 (Pubitemid 41698514)
64. M.D. Fallin, V.K. Lasseter, Y. Liu, D. Avramopoulos, J. McGrath, and P.S. Wolyniec et al. Linkage and association on 8p21.2-p21.1 in schizophrenia Am J Med Genet B Neuropsychiatr Genet 156 2 2010 188 197
65. M.J. Fell, K.A. Svensson, B.G. Johnson, and D.D. Schoepp Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4- amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039) J Pharmacol Exp Ther 326 2008 209 217 (Pubitemid 351872145)
66. K. Fijal, and P. Popik Phencyclidine disturbs relational memory in the transitive inference task Behav Pharmacol 22 262-265 2011 210
67. C.A. Fu, M. Shen, B.C.B. Huang, J. Lasaga, D.G. Payan, and Y. Luo TNIK, a novel member of the germinal center kinase family that activates the c-Jun N-terminal kinase pathway and regulates the cytoskeleton J Biol Chem 274 1999 30729 30737
68. A.J. Funk, R.E. McCullumsmith, V. Haroutunian, and J.H. Meador-Woodruff Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia Neuropsychopharmacology 37 2012 896 905
69. J. Gauthier, N. Champagne, R.G. Lafrenière, L. Xiong, D. Spiegelman, and E. Brustein et al. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia Proc Natl Acad Sci U S A 107 17 2010 7863 7868
70. M. Ghadirivasfi, S. Nohesara, H.R. Ahmadkhaniha, M.R. Eskandari, S. Mostafavi, and S. Thiagalingam et al. Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder Am J Med Genet B Neuropsychiatr Genet 156B 5 2011 536 545
71. S.L. Girard, J. Gauthier, A. Noreau, L. Xiong, S. Zhou, and L. Jouan et al. Increased exonic de novo mutation rate in individuals with schizophrenia Nat Genet 43 9 2011 860 863
72. J.T. Glessner, M.P. Reilly, C.E. Kim, N. Takahashi, A. Albano, and C. Hou et al. Strong synaptic transmission impact by copy number variations in schizophrenia Proc Natl Acad Sci U S A 107 23 2010 10584 10589
73. M.S. Golub, S.L. Germann, and K.C. Lloyd Behavioral characteristics of a nervous system-specific erbB4 knock-out mouse Behav Brain Res 153 1 2004 159 170 (Pubitemid 38829299)
74. D.R. Grayson, Y. Chen, E. Costa, E. Dong, A. Guidotti, and M. Kundakovic et al. The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia Pharmacol Ther 111 1 2006 272 286 (Pubitemid 43765535)
75. M.J. Green, M.J. Cairns, J. Wu, M. Dragovic, A. Jablensky, and P.A. Tooney et al. Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia Mol Psychiatry 18 7 2012 774 780
76. E.K. Green, D. Grozeva, R. Sims, R. Raybould, L. Forty, and K. Gordon-Smith et al. DISC1 exon 11 rare variants found more commonly in schizoaffective spectrum cases than controls Am J Med Genet B Neuropsychiatr Genet 156B 4 2011 490 492
77. G. Gu, D.S. Lorrain, H. Wei, R.L. Cole, X. Zhang, and L.P. Daggett et al. Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: Implication in emotional responses and central disinhibition Brain Res 1197 2008 47 62
78. C. Guidali, D. ViganÃ2, S. Petrosino, E. Zamberletti, N. Realini, and G. Binelli et al. Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine Int J Neuropsychopharmacol 14 2011 17 28
79. A. Guilmatre, C. Dubourg, A.L. Mosca, S. Legallic, A. Goldenberg, and V. Drouin-Garraud et al. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation Arch Gen Psychiatry 66 9 2009 947 956
80. Y. Hakak, J.R. Walker, C. Li, W.H. Wong, K.L. Davis, and J.D. Buxbaum et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia Proc Natl Acad Sci U S A 98 2001 4746 4751 (Pubitemid 32295047)
81. J. Hall, H.C. Whalley, D.E. Job, B.J. Baig, A.M. McIntosh, and K.L. Evans et al. A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms Nat Neurosci 9 2006 1477 1478 (Pubitemid 44862654)
82. P.J. Harrison, and A.J. Law Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology Biol Psychiatry 60 2 2006 132 140
83. P.J. Harrison, L. Lyon, L.J. Sartorius, P.W. Burnet, and T.A. Lane The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia J Psychopharmacol 22 2008 308 322 (Pubitemid 351847454)
84. P.J. Harrison, and D.R. Weinberger Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence Mol Psychiatry 10 1 2005 40 68 (Pubitemid 40139588)
85. T. Hashimoto, D. Arion, T. Unger, J.G. Maldonado-Aviles, H.M. Morris, and D.W. Volk et al. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia Mol Psychiatry 13 2008 147 161
86. R. Hashimoto, R.E. Straub, C.S. Weickert, T.M. Hyde, J.E. Kleinman, and D.R. Weinberger Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia Mol Psychiatry 9 3 2004 299 307 (Pubitemid 38496722)
87. Y. He, Z. Yu, I. Giegling, L. Xie, A.M. Hartmann, and C. Prehn et al. Schizophrenia shows a unique metabolomics signature in plasma Transl Psychiatry 2 2012 e149
88. T. Hikida, N.J. Gamo, and A. Sawa DISC1 as a therapeutic target for mental illnesses Expert Opin Ther Targets 16 2012 1151 1160
89. M.J. Hill, and N.J. Bray Evidence that schizophrenia risk variation in the ZNF804A gene exerts its effects during fetal brain development Am J Psychiatry 169 12 2012 1301 1308
90. M.J. Hill, A.R. Jeffries, R.J. Dobson, J. Price, and N.J. Bray Knockdown of the psychosis susceptibility gene ZNF804A alters expression of genes involved in cell adhesion Hum Mol Genet 21 2011 1018 1024
91. L.E. Hong, I. Wonodi, M.T. Avila, R.W. Buchanan, R.P. McMahon, and B.D. Mitchell et al. Dihydropyrimidinase-related protein 2 (DRP-2) gene and association to deficit and nondeficit schizophrenia Am J Med Genet B Neuropsychiatr Genet 136B 1 2005 8 11 (Pubitemid 40917522)
92. C.R. Hopkins Is there a path forward for mGlu(2) positive allosteric modulators for the treatment of schizophrenia? ACS Chem Neurosci 4 2013 211 213
93. S. Horvath, Z. Janka, and K. Mirnics Analyzing schizophrenia by DNA microarrays Biol Psychiatry 69 2010 157 162
94. S.T. Hou, S.X. Jiang, A. Aylsworth, G. Ferguson, J. Slinn, and H. Hu et al. CaMKII phosphorylates collapsin response mediator protein 2 and modulates axonal damage during glutamate excitotoxicity J Neurochem 111 3 2009 870 881
95. O.D. Howes, and S. Kapur The dopamine hypothesis of schizophrenia: version III - the final common pathway Schizophr Bull 35 2009 549 562
96. H.S. Huang, and S. Akbarian GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia PLoS One 2 2007 e809
97. N.K. Hussain, H. Hsin, R.L. Huganir, and M. Sheng MINK and TNIK differentially act on Rap2-mediated signal transduction to regulate neuronal structure and AMPA receptor function J Neurosci 30 2010 14786 14794
98. M. Ikeda, B. Aleksic, G. Kirov, Y. Kinoshita, Y. Yamanouchi, and T. Kitajima et al. Copy number variation in schizophrenia in the Japanese population Biol Psychiatry 67 2010 283 286
99. A. Ingason, D. Rujescu, S. Cichon, E. Sigurdsson, T. Sigmundsson, and O.P. Pietiläinen et al. Copy number variations of chromosome 16p13.1 region associated with schizophrenia Mol Psychiatry 16 1 2011 17 25
100. Irish Schizophrenia Genomics Consortium and the Wellcome Trust Case Control Consortium 2 Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia Biol Psychiatry 72 2012 620 628
101. K. Iwamoto, M. Bundo, and T. Kato Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis Hum Mol Genet 14 2005 241 253
102. J.D. Jentsch, and R.H. Roth The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia Neuropsychopharmacology 20 1999 201 225 (Pubitemid 29067401)
103. P. Jia, L. Wang, A.H. Fanous, X. Chen, K.S. Kendler, and Z. Zhao A bias-reducing pathway enrichment analysis of genome-wide association data confirmed association of the MHC 2012
104. N.L. Johnston-Wilson, C.D. Sims, J.P. Hofmann, L. Anderson, A.D. Shore, and E.F. Torrey et al. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium Mol Psychiatry 5 2 2000 142 149 (Pubitemid 30229428)
105. J. Joo, S. Lee, S.S. Nah, Y.O. Kim, D.S. Kim, and S.H. Shim et al. Lasp1 is down-regulated in NMDA receptor antagonist-treated mice and implicated in human schizophrenia susceptibility J Psychiatr Res 47 1 2013 105 112
106. A.K. Kähler, M.K. Otnæss, K.V. Wirgenes, T. Hansen, E.G. Jönsson, and I. Agartz et al. Association study of PDE4B gene variants in scandinavian schizophrenia and bipolar disorder multicenter case-control samples Am J Med Genet B Neuropsychiatr Genet 153B 2010 86 96
107. S. Kapur, A.G. Phillips, and T.R. Insel Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol Psychiatry 17 12 2012 174 179
108. M. Karayiorgou, T.J. Simon, and J.A. Gogos 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia Nat Rev Neurosci 11 2010 402 416
109. R. Khanna, S.M. Wilson, J.M. Brittain, J. Weimer, R. Sultana, and A. Butterfield et al. Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders Future Neurol 7 2012 749 771
110. G. Kirov, D. Grozeva, N. Norton, D. Ivanov, K.K. Mantripragada, and P. Holmans et al. Support for the involvement of large copy number variants in the pathogenesis of schizophrenia Hum Mol Genet 18 2009 1497 1503
111. G. Kirov, M.C. O'Donovan, and M.J. Owen Finding schizophrenia genes J Clin Invest 115 2005 1440 1448 (Pubitemid 40814648)
112. G. Kirov, A.J. Pocklington, P. Holmans, D. Ivanov, M. Ikeda, and D. Ruderfer et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia Mol Psychiatry 17 2012 142 153
113. H.M. Knight, B.S. Pickard, A. Maclean, M.P. Malloy, D.C. Soares, and A.F. McRae et al. A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depression Am J Hum Genet 85 6 2009 833 846
114. T. Koide, B. Aleksic, Y. Ito, H. Usui, A. Yoshimi, and T. Inada et al. A two-stage case-control association study of the dihydropyrimidinase-like 2 gene (DPYSL2) with schizophrenia in Japanese subjects J Hum Genet 55 7 2010 469 472
115. A. Konrad, G. Vucurevic, F. Musso, P. Stoeter, N. Dahmen, and G. Winterer ErbB4 genotype predicts left frontotemporal structural connectivity in human brain Neuropsychopharmacology 34 3 2009 641 650
116. J.H. Krystal, L.P. Karper, J.P. Seibyl, G.K. Freeman, R. Delaney, and J.D. Bremner et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch Gen Psychiatry 51 1994 199 214 (Pubitemid 24081509)
117. E. Kwon, W. Wang, and L.H. Tsai Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets Mol Psychiatry 18 2013 11 12
118. A.J. Law, J.E. Kleinman, D.R. Weinberger, and C.S. Weickert Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia Hum Mol Genet 16 2 2007 129 141 (Pubitemid 46178996)
119. A.J. Law, B.K. Lipska, C.S. Weickert, T.M. Hyde, R.E. Straub, and R. Hashimoto et al. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease Proc Natl Acad Sci U S A 103 17 2006 6747 6752
120. A.J. Law, Y. Wang, Y. Sei, P. O'Donnell, P. Piantadosi, and F. Papaleo et al. Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy Proc Natl Acad Sci U S A 109 30 2012 12165 12170
121. S.M. Lawrie, and S.S. Abukmeil Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies Br J Psychiatry 172 1998 110 120 (Pubitemid 28097708)
122. E.D. Levin α7-Nicotinic receptors and cognition Curr Drug Targets 13 2012 602 606
123. D.F. Levinson, J. Duan, S. Oh, K. Wang, A.R. Sanders, and J. Shi et al. Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications Am J Psychiatry 168 2011 302 316
124. D.F. Levinson, J. Shi, K. Wang, S. Oh, B. Riley, and A.E. Pulver et al. Genome-wide association study of multiplex schizophrenia pedigrees Am J Psychiatry 169 9 2012 963 973
125. C.M. Lewis, D.F. Levinson, L.H. Wise, L.E. DeLisi, R.E. Straub, and I. Hovatta et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia Am J Hum Genet 73 2003 34 48 (Pubitemid 36793778)
126. J.A. Lieberman, and T.S. Stroup The NIMH-CATIE schizophrenia study: what did we learn? Am J Psychiatry 168 2011 770 775
127. J.A. Lieberman, T.S. Stroup, J.P. McEvoy, M.S. Swartz, R.A. Rosenheck, and D.O. Perkins et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia N Engl J Med 353 2005 1209 1223 (Pubitemid 41345943)
128. A.C. Lionel, A.K. Vaags, D. Sato, M.J. Gazzellone, E.B. Mitchell, and H.Y. Chen et al. Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures Hum Mol Genet 22 10 2013 2055 2066
129. Y. Mao, X. Ge, C.L. Frank, J.M. Madison, A.N. Koehler, and M.K. Doud et al. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3b-catenin signaling Cell 136 2009 1017 1031
130. S. Marenco, M. Geramita, J.W. van der Veen, A.S. Barnett, B. Kolachana, and J. Shen et al. Genetic association of ErbB4 and human cortical GABA levels in vivo J Neurosci 31 32 2011 11628 11632
131. D. Martins-De-Souza, E. Dias-Neto, A. Schmitt, P. Falkai, P. Gormanns, and G. Maccarrone et al. Proteome analysis of schizophrenia brain tissue World J Biol Psychiatry 11 2 2010 110 120
132. D. Martins-de-Souza, W.F. Gattaz, A. Schmitt, G. Maccarrone, E. Hunyadi-Gulyás, and M.N. Eberlin et al. Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia J Psychiatr Res 43 11 2009 978 986
133. S.V. Mathew, A.J. Law, B.K. Lipska, M.I. Dávila-García, E.D. Zamora, S.N. Mitkus, R. Vakkalanka, R.E. Straub, D.R. Weinberger, J.E. Kleinman, and T.M. Hyde Alpha7 nicotinic acetylcholine receptor mRNA expression and binding in postmortem human brain are associated with genetic variation in neuregulin 1 Hum Mol Genet. 16 23 2007 2921 2932 (Pubitemid 350048389)
134. N. Matigian, G. Abrahamsen, R. Sutharsan, A.L. Cook, A.M. Vitale, and A. Nouwens et al. Disease-specific, neurosphere-derived cells as models for brain disorders Dis Model Mech 3 2010 785 798
135. S.E. McCarthy, V. Makarov, G. Kirov, A.M. Addington, J. McClellan, and S. Yoon et al. Microduplications of 16p11.2 are associated with schizophrenia Nat Genet 41 11 2009 1223 1227
136. A.M. McIntosh, B.J. Baig, L.J. Hal, D. Job, H.C. Whalley, and G.K. Lymer et al. Relationship of catechol-O-methyltransferase variants to brain structure and function in a population at high risk of psychosis Biol Psychiatry 61 10 2007 1127 1134 (Pubitemid 46669452)
137. Medtrack Medtrack http://www.medtrack.com 2012
138. L. Mei, and W.C. Xiong Neuregulin 1 in neural development, synaptic plasticity and schizophrenia Nat Rev Neurosci 9 2008 437 452 (Pubitemid 351704944)
139. F.A. Middleton, K. Mirnics, J.N. Pierri, D.A. Lewis, and P. Levitt Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia J Neurosci 22 2002 2718 2729 (Pubitemid 37465821)
140. J. Mill, T. Tang, Z. Kaminsky, T. Khare, S. Yazdanpanah, and L. Bouchard et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis Am J Hum Genet 82 3 2008 696 711 (Pubitemid 351726115)
141. J.K. Millar, B.S. Pickard, S. Mackie, R. James, S. Christie, and S.R. Buchanan et al. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling Science 310 2005 1187 1191 (Pubitemid 41681745)
142. J.K. Millar, J.C. Wilson-Annan, S. Anderson, S. Christie, M.S. Taylor, and C.A. Semple et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia Hum Mol Genet 9 9 2000 1415 1423 (Pubitemid 30312490)
143. K. Mirnics, F.A. Middleton, A. Marquez, D.A. Lewis, and P. Levitt Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex Neuron 28 2000 53 67
144. K.J. Mitchell, and D.J. Porteous Rethinking the genetic architecture of schizophrenia Psychol Med 1-14 2010
145. L.N. Moens, P. De Rijk, J. Reumers, M.J. Van den Bossche, W. Glassee, and S. De Zutter et al. Sequencing of DISC1 pathway genes reveals increased burden of rare missense variants in schizophrenia patients from a northern Swedish population PLoS One 6 8 2011 e23450
146. B. Moghaddam, and J.H. Krystal Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans Schizophr Bull 38 5 2012 942 949
147. T.M. Moore, R. Garg, C. Johnson, M.J. Coptcoat, A.J. Ridley, and J.D.H. Morris PSK, a novel STE20-like kinase derived from prostatic carcinoma that activates the c-Jun N-terminal kinase mitogen-activated protein kinase pathway and regulates actin cytoskeletal organization J Biol Chem 275 2000 4311 4322 (Pubitemid 30094672)
148. M.P. Moreau, S.E. Bruse, R. David-Rus, S. Buyske, and L.M. Brzustowicz Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder Biol Psychiatry 69 2011 188 193
149. C.J.A. Morgan, S. Duffin, S. Hunt, L. Monaghan, O. Mason, and H.V. Curran Neurocognitive function and schizophrenia-proneness in individuals dependent on ketamine, on high potency cannabis ('skunk') or on cocaine Pharmacopsychiatry 45 2012 269 274
150. B.J. Morris, S.M. Cochran, and J.A. Pratt PCP: from pharmacology to modelling schizophrenia Curr Opin Pharmacol 5 2005 1 6
151. P. Muglia From genes to therapeutic targets for psychiatric disorders - what to expect? Curr Opin Pharmacol 11 2011 563 571
152. J.G. Mulle, A.F. Dodd, J.A. McGrath, P.S. Wolyniec, A.A. Mitchell, and A.C. Shetty et al. Microdeletions of 3q29 confer high risk for schizophrenia Am J Hum Genet 87 2 2010 229 236
153. R.A. Myers, F. Casals, J. Gauthier, F.F. Hamdan, J. Keebler, and A.R. Boyko et al. A population genetic approach to mapping neurological disorder genes using deep resequencing PLoS Genet 7 2 2011 e1001318
154. K. Nakata, H. Ujike, A. Sakai, M. Takaki, T. Imamura, and Y. Tanaka et al. The human dihydropyrimidinase-related protein 2 gene on chromosome 8p21 is associated with paranoid-type schizophrenia Biol Psychiatry 53 7 2003 571 576 (Pubitemid 36385058)
155. A.C. Need, D. Ge, M.E. Weale, J. Maia, S. Feng, and E.L. Heinzen et al. A genome-wide investigation of SNPs and CNVs in schizophrenia PLoS Genet 5 2009 e1000373
156. A.C. Need, J.P. McEvoy, M. Gennarelli, E.L. Heinzen, D. Ge, and J.M. Maia et al. Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia Am J Hum Genet 91 2 2012 303 312
157. M.Y. Ng, D.F. Levinson, S.V. Faraone, B.K. Suarez, L.E. DeLisi, T. Arinami, B. Riley, T. Paunio, A.E. Pulver, Irmansyah, P.A. Holmans, M. Escamilla, D.B. Wildenauer, N.M. Williams, C. Laurent, B.J. Mowry, L.M. Brzustowicz, M. Maziade, P. Sklar, D.L. Garver, G.R. Abecasis, B. Lerer, M.D. Fallin, H.M. Gurling, P.V. Gejman, E. Lindholm, H.W. Moises, W. Byerley, E.M. Wijsman, P. Forabosco, M.T. Tsuang, H.G. Hwu, Y. Okazaki, K.S. Kendler, B. Wormley, A. Fanous, D. Walsh, F.A. O'Neill, L. Peltonen, G. Nestadt, V.K. Lasseter, K.Y. Liang, G.M. Papadimitriou, D.G. Dikeos, S.G. Schwab, M.J. Owen, M.C. O'Donovan, N. Norton, E. Hare, H. Raventos, H. Nicolini, M. Albus, W. Maier, V.L. Nimgaonkar, L. Terenius, J. Mallet, M. Jay, S. Godard, D. Nertney, M. Alexander, R.R. Crowe, J.M. Silverman, A.S. Bassett, M.A. Roy, C. Merette, C.N. Pato, M.T. Pato, J.L. Roos, Y. Kohn, D. Amann-Zalcenstein, G. Kalsi, A. McQuillin, D. Curtis, J. Brynjolfson, T. Sigmundsson, H. Petursson, A.R. Sanders, J. Duan, E. Jazin, M. Myles-Worsley, M. Karayiorgou, and C.M. Lewis Meta-analysis of 32 genome-wide linkage studies of schizophrenia Mol Psychiatry 14 2009 774 785
158. S. Nohesara, M. Ghadirivasfi, S. Mostafavi, M.R. Eskandari, H. Ahmadkhaniha, and S. Thiagalingam et al. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder J Psychiatr Res 45 11 2011 1432 1438
159. N. Norton, V. Moskvina, D.W. Morris, N.J. Bray, S. Zammit, N.M. Williams, H.J. Williams, A.C. Preece, S. Dwyer, J.C. Wilkinson, G. Spurlock, G. Kirov, P. Buckland, J.L. Waddington, M. Gill, A.P. Corvin, M.J. Owen, and M.C. O'Donovan Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia Am J Med Genet B Neuropsychiatr Genet. 41B 1 2006 96 101 (Pubitemid 43062550)
160. M.C. O'Donovan, N. Craddock, N. Norton, H. Williams, T. Peirce, and V. Moskvina et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up Nat Genet 40 2008 1053 1055
161. C.M. O'Tuathaigh, D. Babovic, G.J. O'Sullivan, J.J. Clifford, O. Tighe, and D.T. Croke et al. Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1 Neuroscience 147 1 2007 18 27 (Pubitemid 46873845)
162. M.J. Owen, N.M. Williams, and M.C. O'Donovan The molecular genetics of schizophrenia: new findings promise new insights Mol Psychiatry 9 2004 14 27 (Pubitemid 38175078)
163. Yuji Ozeki, Benjamin S Pickard, Shin-ichi Kano, Mary P. Malloy, Mariela Zeledon, Daniel Q. Sun, Kumiko Fujii, Keiko Wakui, Yukihiko Shirayama, Yoshimitsu Fukushima, Hiroshi Kunugi, Kenji Hashimoto, Walter J. Muir, Douglas H. Blackwood, and Akira Sawa A novel balanced chromosomal translocation found in subjects with schizophrenia and schizotypal personality disorder: altered l-serine level associated with disruption of PSAT1 gene expression Neuroscience Research 69 2 2011 54 60
164. S.T. Patil, L. Zhang, F. Martenyi, S.L. Lowe, K.A. Jackson, and B.V. Andreev et al. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial Nat Med 13 2007 1102 1107 (Pubitemid 47517511)
165. L. Paulson, P. Martin, C.L. Nilsson, E. Ljung, A. Westman-Brinkmalm, and K. Blennow et al. Comparative proteome analysis of thalamus in MK-801-treated rats Proteomics 4 3 2004 819 825 (Pubitemid 38339159)
166. S. Peineau, C. Taghibiglou, C. Bradley, T.P. Wong, L. Liu, and J. Lu et al. LTP inhibits LTD in the hippocampus via regulation of GSK3b Neuron 53 2007 703 717 (Pubitemid 46283369)
167. K. Pennington, P. Dicker, M.J. Dunn, and D.R. Cotter Proteomic analysis reveals protein changes within layer 2 of the insular cortex in schizophrenia Proteomics 8 2008 5097 5107
168. B. Pickard Progress in defining the biological causes of schizophrenia Expert Rev Mol Med 13 2011 e25
169. B.S. Pickard, M.P. Malloy, A. Christoforou, P.A. Thomson, K.L. Evans, and S.W. Morris et al. Cytogenetic and genetic evidence supports a role for the kainate-type glutamate receptor gene, GRIK4, in schizophrenia and bipolar disorder Mol Psychiatry 11 9 2006 847 857 (Pubitemid 44299106)
170. B.S. Pickard, M.P. Malloy, D.J. Porteous, D.H. Blackwood, and W.J. Muir Disruption of a brain transcription factor, NPAS3, is associated with schizophrenia and learning disability Am J Med Genet B Neuropsychiatr Genet 136B 1 2005 26 32 (Pubitemid 40917524)
171. B.S. Pickard, J.K. Millar, D.J. Porteous, W.J. Muir, and D.H. Blackwood Cytogenetics and gene discovery in psychiatric disorders Pharmacogenomics J 5 2005 81 88 (Pubitemid 40468114)
172. C. Pickering, M. Ericson, and B. Söderpalm Chronic phencyclidine increases synapsin-1 and synaptic adaptation proteins in the medial prefrontal cortex ISRN Psychiatry 2013 10.1155/2013/620361
173. D.J. Porteous, J.K. Millar, N.J. Brandon, and A. Sawa DISC1 at 10: connecting psychiatric genetics and neuroscience Trends Mol Med 17 12 2011 699 706
174. D.J. Porteous, P. Thomson, N.J. Brandon, and J.K. Millar The genetics and biology of DISC1 - an emerging role in psychosis and cognition Biol Psychiatry 60 2 2006 123 131
175. S.G. Potkin, J.A. Turner, J.A. Fallon, A. Lakatos, D.B. Keator, and G. Guffanti et al. Gene discovery through imaging genetics: identification of two novel genes associated with schizophrenia Mol Psychiatry 14 2008 416 428
176. S.G. Potkin, J.A. Turner, G. Guffanti, A. Lakatos, J.H. Fallon, and D.D. Nguyen et al. A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype Schizophr Bull 35 2009 96 108
177. S. Prabakaran, J.E. Swatton, M.M. Ryan, S.J. Huffaker, J.T. Huang, and J.L. Griffin et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress Mol Psychiatry 9 7 2004 684 697 (Pubitemid 38932173)
178. J. Pratt, C. Winchester, N. Dawson, and B. Morris Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap Nat Rev Drug Discov 11 2012 560 579
179. J.A. Pratt, C.L. Winchester, A. Egerton, S.M. Cochran, and B.J. Morris Modelling prefrontal cortex deficits in schizophrenia: implications for treatment Br J Pharmacol 153 2008 S465 S470
180. S.M. Purcell, N.R. Wray, J.L. Stone, P.M. Visscher, M.C. O'Donovan, and P.F. Sullivan et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder Nature 460 2009 748 752
181. M. Rimer, D.W. Barrett, M.A. Maldonado, V.M. Vock, and F. Gonzalez-Lima Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition Neuroreport 16 3 2005 271 275 (Pubitemid 40364589)
182. M.A. Rizig, A. McQuillin, A. Ng, M. Robinson, A. Harrison, and M. Zvelebil et al. A gene expression and systems pathway analysis of the effects of clozapine compared to haloperidol in the mouse brain implicates susceptibility genes for schizophrenia J Psychopharmacol 26 9 2012 1218 1230
183. W. Rossler, H.J. Salize, J. van Os, and A. Riecher-Rossler Size of burden of schizophrenia and psychotic disorders Eur Neuropsychopharmacol 15 2005 399 409 (Pubitemid 40943544)
184. J. Sebat, D.L. Levy, and S.E. McCarthy Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders Trends Genet 25 12 2009 528 535
185. P.A. Sequeira, M.V. Martin, and M.P. Vawter The first decade and beyond of transcriptional profiling in schizophrenia Neurobiol Dis 45 1 2012 23 36
186. A. Shamir, O.B. Kwon, I. Karavanova, D. Vullhorst, E. Leiva-Salcedo, and M.J. Janssen et al. The importance of the NRG-1/ErbB4 pathway for synaptic plasticity and behaviors associated with psychiatric disorders J Neurosci 32 9 2012 2988 2997
187. D.J. Sheffler, A.B. Pinkerton, R. Dahl, A. Markou, and N.D. Cosford Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators ACS Chem Neurosci 2 2012 382 393
188. Y.C. Shen, D.L. Liao, J.Y. Chen, Y.C. Wang, I.C. Lai, and Y.J. Liou et al. Exomic sequencing of the ionotropic glutamate receptor N-methyl-d-aspartate 3A gene (GRIN3A) reveals no association with schizophrenia Schizophr Res 114 1-3 2009 25 32
189. J. Shi, D.F. Levinson, J. Duan, A.R. Sanders, Y. Zheng, and I. Pe'er et al. Common variants on chromosome 6p22.1 are associated with schizophrenia Nature 460 2009 753 757
190. Y. Shi, Z. Li, Q. Xu, T. Wang, T. Li, and J. Shen et al. Common variants on 8p12 and 1q24.2 confer risk of schizophrenia Nat Genet 43 2011 1224 1227
191. G. Silberberg, A. Darvasi, R. Pinkas-Kramarski, and R. Navon The involvement of ErbB4 with schizophrenia: association and expression studies Am J Med Genet B Neuropsychiatr Genet 141B 2 2006 142 148 (Pubitemid 43214789)
192. S. Sivagnanasundaram, B. Crossett, I. Dedova, S. Cordwell, and I. Matsumoto Abnormal pathways in the genu of the corpus callosum in schizophrenia pathogenesis: a proteome study Proteomics Clin Appl 1 10 2007 1291 1305
193. R.D. Smrt, K.E. Szulwach, R.L. Pfeiffer, X. Li, W. Guo, and M. Pathania et al. MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1 Stem Cells 28 2010 1060 1070
194. D.C. Soares, B.C. Carlyle, N.J. Bradshaw, and D.J. Porteous DISC1: structure, function, and therapeutic potential for major mental illness ACS Chem Neurosci 2 11 2011 609 632
195. W. Song, W. Li, J. Feng, L.L. Heston, W.A. Scaringe, and S.S. Sommer Identification of high risk DISC1 structural variants with a 2% attributable risk for schizophrenia Biochem Biophys Res Commun 367 3 2008 700 706
196. J.R. Spencer, K.M. Darbyshire, A.A. Boucher, M.A. Kashem, L.E. Long, and I.S. McGregor et al. Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice Front Cell Neurosci 7 2013 15 (doi: 10.3389)
197. D. St Clair, D. Blackwood, W. Muir, A. Carothers, M. Walker, and G. Spowart et al. Association within a family of a balanced autosomal translocation with major mental illness Lancet 336 8706 1990 13 16 (Pubitemid 20207869)
198. H. Stefansson, R.A. Ophoff, S. Steinberg, O.A. Andreassen, S. Cichon, and D. Rujescu et al. Common variants conferring risk of schizophrenia Nature 460 2009 744 747
199. H. Stefansson, D. Rujescu, S. Cichon, O.P. Pietilainen, A. Ingason, and S. Steinberg et al. Large recurrent microdeletions associated with schizophrenia Nature 455 2008 232 236
200. H. Stefansson, E. Sigurdsson, V. Steinthorsdottir, S. Bjornsdottir, T. Sigmundsson, and S. Ghosh et al. Neuregulin 1 and susceptibility to schizophrenia Am J Hum Genet 71 4 2002 877 892 (Pubitemid 135750519)
201. S. Steinberg, S. de Jong, Irish Schizophrenia Genomics Consortium, A. Andreassen, T. Werge, and A.D. Børglum et al. Common variants at VRK2 and TCF4 conferring risk of schizophrenia Hum Mol Genet 20 9 2011 4076 4081
202. S. Steinberg, S. de Jong, M. Mattheisen, J. Costas, D. Demontis, and S. Jamain et al. Common variant at 16p11.2 conferring risk of psychosis Mol Psychiatry 2012 10.1038/mp.2012.157
203. T. Sugai, M. Kawamura, S. Iritani, K. Araki, T. Makifuchi, and C. Imai et al. Prefrontal abnormality of schizophrenia revealed by DNA microarray: impact on glial and neurotrophic gene expression Ann N Y Acad Sci 1025 2004 84 91 (Pubitemid 39643849)
204. P.F. Sullivan, K.S. Kendler, and M.C. Neale Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies Arch Gen Psychiatry 60 12 2003 1187 1192 (Pubitemid 37494071)
205. G. Sun, P. Ye, K. Murai, M.F. Lang, S. Li, and H. Zhang et al. miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells Nat Commun 2 2011 529 (doi: 10.1038)
206. L.P. Sutton, and W.J. Rushlow Regulation of Akt and Wnt signaling by the group II metabotropic glutamate receptor antagonist LY341495 and agonist LY379268 J Neurochem 117 2011 973 983
207. K.E. Szulwach, X. Li, R.D. Smrt, Y. Li, Y. Luo, and L. Lin et al. Cross talk between microRNA and epigenetic regulation in adult neurogenesis J Cell Biol 189 2010 127 141
208. G.W. Tam, L.N. van de Lagemaat, R. Redon, K.E. Strathdee, M.D. Croning, and M.P. Malloy et al. Confirmed rare copy number variants implicate novel genes in schizophrenia Biochem Soc Trans 38 2010 445 451
209. J. Tarabeux, N. Champagne, E. Brustein, F.F. Hamdan, J. Gauthier, and M. Lapointe et al. De novo truncating mutation in Kinesin 17 associated with schizophrenia Biol Psychiatry 68 7 2010 649 656
210. J. Tarabeux, O. Kebir, J. Gauthier, F.F. Hamdan, L. Xiong, and A. Piton et al. Rare mutations in N-methyl-d-aspartate glutamate receptors in autism spectrum disorders and schizophrenia Transl Psychiatry 1 2011 e55
211. The International Schizophrenia Consortium Rare chromosomal deletions and duplications increase risk of schizophrenia Nature 455 2008 237 241
212. The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium Genome-wide association study identifies five new schizophrenia loci Nat Genet 43 2011 969 976
213. D. Thomson, A. McVie, B. Morris, and J. Pratt Dissociation of acute and chronic intermittent phencyclidine-induced performance deficits in the 5-choice serial reaction time task: influence of clozapine Psychopharmacology (Berl) 213 2011 681 695
214. S.J. Tsai, C.Y. Cheng, C.J. Hong, D.L. Liao, S.J. Hou, and F.C. Yen et al. Association study of polymorphisms in glycine transporter with schizophrenia J Neural Transm 113 10 2006 1545 1549
215. A. Tsolakidou, D. Trumbach, M. Panhuysen, B. Putz, J. Deussing, W. Wurst, I. Sillaber, F. Holsboer, and T. Rein Acute stress regulation of neuroplasticity genes in mouse hippocampus CA3 area-possible novel signalling pathways Mol Cell Neurosci 38 2008 444 452
216. Y. Uchida, T. Ohshima, Y. Sasaki, H. Suzuki, S. Yanai, and N. Yamashita et al. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease Genes Cells 10 2 2005 165 179 (Pubitemid 40287519)
217. H. Ujike, A. Sakai, K. Nakata, Y. Tanaka, T. Kodaka, and Y. Okahisa et al. Association study of the dihydropyrimidinase-related protein 2 gene and methamphetamine psychosis Ann N Y Acad Sci 1074 2006 90 96 (Pubitemid 44532813)
218. V. Vacic, S. McCarthy, D. Malhotra, F. Murray, H.H. Chou, and A. Peoples et al. Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia Nature 471 7339 2011 499 503
219. M.J. Van Den Bossche, M. Johnstone, M. Strazisar, B.S. Pickard, D. Goossens, and A.S. Lenaerts et al. Rare copy number variants in neuropsychiatric disorders: specific phenotype or not? Am J Med Genet B Neuropsychiatr Genet 159B 2012 812 822
220. M.P. Vawter, J.M. Crook, T.M. Hyde, J.E. Kleinman, D.R. Weinberger, and K.G. Becker et al. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study Schizophr Res 58 2002 11 20 (Pubitemid 35287279)
221. D. Vigano, C. Guidali, S. Petrosino, N. Realini, T. Rubino, and V. Di Marzo et al. Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia Int J Neuropsychopharmacol 12 2009 599 614
222. T. Vrijenhoek, J.E. Buizer-Voskamp, I. van der Stelt, E. Strengman, Genetic Risk and Outcome in Psychosis (GROUP) Consortium, and C. Sabatti et al. Recurrent CNVs disrupt three candidate genes in schizophrenia patients Am J Hum Genet 83 4 2008 504 510
223. T.L. Wallace, and R.H.P. Porter Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease Biochem Pharmacol 82 2011 891 903
224. T. Walsh, J.M. McClellan, S.E. McCarthy, A.M. Addington, S.B. Pierce, and G.M. Cooper et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia Science 320 2008 539 543 (Pubitemid 351590668)
225. C. Walss-Bass, W. Liu, D.F. Lew, R. Villegas, P. Montero, and A. Dassori et al. A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia Biol Psychiatry 60 6 2006 548 553 (Pubitemid 44402371)
226. Q. Wang, E.I. Charych, V.L. Pulito, J.B. Lee, N.M. Graziane, and R.A. Crozier et al. The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function Mol Psychiatry 16 2011 1006 1023
227. Q. Wang, H. Jaaro-Peled, A. Sawa, and N.J. Brandon How has DISC1 enabled drug discovery? Mol Cell Neurosci 37 2 2008 187 195 (Pubitemid 351173852)
228. T.H. Wassink, E.A. Epping, D. Rudd, M. Axelsen, S. Ziebell, and F.W. Fleming et al. Influence of ZNF804A on brain structure volumes and symptom severity in individuals with schizophrenia Arch Gen Psychiatry 69 9 2012 885 892
229. H.C. Whalley, M. Papmeyer, L. Romaniuk, E. Sprooten, E.C. Johnstone, and J. Hall et al. Impact of a microRNA MIR137 susceptibility variant on brain function in people at high genetic risk of schizophrenia or bipolar disorder Neuropsychopharmacology 37 2012 2720 2729
230. WHO New understanding, new hope World Health Report http://www.who.int/ whr/2001/en/ 2001
231. M.H. Willemsen, A. Vallès, L.A. Kirkels, M. Mastebroek, N. Olde Loohuis, and A. Kos et al. Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability J Med Genet 48 12 2011 810 818
232. C.L. Winchester, G.M. Hamilton, B. Morris, J.A. Pratt, R. Hunter, and M.E.S. Bailey Using next generation sequencing to investigate DPYSL2 gene variants in schizophrenia J Psychopharmacol 25 8 2011 A67 (Supplement S)
233. C. Winchester, H. Ohzeki, J.M. Pratt, and B.J. Morris Identification of schizophrenia-related genes by global transcriptome analysis of the prefrontal cortex of PCP treated rats J Physiol Proc Life Sci C4 2007
234. C.L. Winchester, H. Ohzeki, D.A. Vouyiouklis, R. Thompson, J.M. Penninger, and K. Yamagami et al. Converging evidence that sequence variations in the novel candidate gene MAP2K7 (MKK7) are functionally associated with schizophrenia Hum Mol Genet 21 2012 4910 4921
235. M. Woolley, D. Pemberton, S. Bate, C. Corti, and D. Jones The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity Psychopharmacology (Berl) 196 2008 431 440
236. J.Q. Wu, X. Wang, N.J. Beveridge, P.A. Tooney, R.J. Scott, and V.J. Carr et al. Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia PLoS One 7 2012 e36351
237. B. Xu, J.L. Roos, P. Dexheimer, B. Boone, B. Plummer, and S. Levy et al. Exome sequencing supports a de novo mutational paradigm for schizophrenia Nat Genet 43 9 2011 864 868
238. T. Yamasaki, H. Kawasaki, S. Arakawa, K. Shimizu, S. Shimizu, and O. Reiner et al. Stress-activated protein kinase MKK7 regulates axon elongation in the developing cerebral cortex J Neurosci 31 2011 16872 16883
239. L. Yu, N. Arbez, L.G. Nucifora, G.L. Sell, L.E. Delisi, and C.A. Ross et al. A mutation in NPAS3 segregates with mental illness in a small family Mol Psychiatry 2013 10.1038
240. X. Zhao, R. Tang, Z. Xiao, Y. Shi, G. Feng, and N. Gu et al. An investigation of the dihydropyrimidinase-like 2 (DPYSL2) gene in schizophrenia: genetic association study and expression analysis Int J Neuropsychopharmacol 9 6 2006 705 712 (Pubitemid 46122770)
241. C. Zihni, C. Mitsopoulos, I.A. Tavares, B. Baum, A.J. Ridley, and J.D.H. Morris Prostate-derived sterile 20-like kinase 1 induces apoptosis: JNK- and caspase-dependent nuclear localization is a requirement for membrane blebbing J Biol Chem 282 2007 6484 6493 (Pubitemid 47100886)
242. E. Zmuda-Trzebiatowska, V. Manganiello, and E. Degerman Novel mechanisms of the regulation of protein kinase B in adipocytes; implications for protein kinase A, Epac, phosphodiesterases 3 and 4 Cell Signal 19 2007 81 86 (Pubitemid 44895447)